American College of Cardiology issues scientific statement on inflammation and cardiovascular disease
2025-09-29
(Press-News.org) WASHINGTON (September 29, 2025) — The American College of Cardiology (ACC) released today its second Scientific Statement, Inflammation and Cardiovascular Disease (CVD). The statement emphasizes years of clinical and basic science research, confirming that inflammation is an important underlying contributor to several CVDs, including coronary artery disease and heart failure.
Key Points:
High-sensitivity C-reactive protein (hsCRP) is an inexpensive and widely available blood test. While there has been debate within the medical community regarding the utility of hsCRP, this statement details the data confirming its value in clinical decision making in primary and secondary prevention.
In patients with known CVD, hsCRP level is at least as predictive of future events as LDL cholesterol levels, even in patients treated with statin therapy.
The important role of lifestyle interventions to reduce systemic inflammation is emphasized, including regular exercise (at least 150 minutes/week), Mediterranean or DASH Diet, and intake of omega-3 fatty acids, including two to three meals per week of fatty fish high in EPA and DHA. This advice aligns with lifestyle management recommendations in the 2025 ACC/AHA High Blood Pressure Guideline
The statement was published in JACC, the flagship journal of the American College of Cardiology (link live at embargo lift).
To receive an embargoed copy of the statement, contact Olivia Walther at owalther@acc.org.
The American College of Cardiology (ACC) is a global leader dedicated to transforming cardiovascular care and improving heart health for all. For more than 75 years, the ACC has empowered a community of over 60,000 cardiovascular professionals across more than 140 countries with cutting-edge education and advocacy, rigorous professional credentials, and trusted clinical guidance. From its world-class JACC Journals and NCDR registries to its Accreditation Services, global network of Chapters and Sections, and CardioSmart patient initiatives, the College is committed to creating a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or connect on social media at @ACCinTouch.
The ACC’s JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-09-29
A new study applying multi-omics techniques and machine learning identified 33 plasma proteins that differ significantly in patients with amyotrophic lateral sclerosis (ALS). The findings suggest ALS could be detected up to 10 years before symptoms appear, offering promise for reliable diagnostic biomarkers.
The integration of advanced high-throughput sequencing technologies, such as whole genome sequencing (WGS) for the early detection of rare diseases, such as ALS, could give clinicians and patients a critical window for ...
2025-09-29
University of Oregon researchers have tested a new combination drug therapy that could dismantle the difficult-to-treat bacteria inhabiting chronic wound infections.
Their findings, published Sept. 29 in the journal Applied and Environmental Microbiology, illuminate ways to develop more effective antimicrobial treatments that promote healing in chronic wounds. Such treatments also could help reduce the risk of severe infections that sometimes lead to amputations, such as diabetic foot ulcers.
Funded by the National Institutes of Health, the approach pairs long-known substances that do little ...
2025-09-29
AMHERST, Mass. — Researchers from the University of Massachusetts Amherst are part of a team that has identified a unique mineral on Mars, described in Nature Communications. Named ferric hydroxysulfate, the mineral provides clues about the Martian environment and history of the planet, including the possibility of former lava, ash or hydrothermal activity.
Mars gets its trademark red hue from the abundance of iron on its surface, but that’s just what can be seen with the naked eye. The various minerals on ...
2025-09-29
DALLAS, Sept 29, 2025 — Megan McLaughlin, M.D., M.P.H., an assistant professor of medicine in the division of cardiology at University of California, San Francisco (UCSF), has been selected to receive the 2025 Dr. Nanette K. Wenger Research Goes Red® Award at the American Heart Association’s Scientific Sessions 2025. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The award will be presented to Dr. McLaughlin during the annual Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular ...
2025-09-29
Researchers investigate clean and efficient new method for iron production
MINNEAPOLIS / ST. PAUL (09/29/2025) — A research team at the University of Minnesota Twin Cities has investigated a new method to produce iron, the main component of steel. For the first time, the researchers were able to observe chemical reactions and iron formation in real-time at the nanometer scale.
This breakthrough has the potential to transform the global iron and steel production industry by improving energy efficiency ...
2025-09-29
A team of scientists at Texas Tech University Health Sciences Center (TTUHSC) has published new evidence suggesting that the brain’s protective shield — known as the blood-brain barrier (BBB) — remains largely intact in a commonly used mouse model of Alzheimer’s disease. The discovery challenges long-standing assumptions that Alzheimer’s disease causes the BBB to “leak,” potentially reshaping how researchers think about drug delivery for the disease.
The study, published July 23 in Fluids and Barriers of the CNS, was conducted by a research team ...
2025-09-29
A new class of highly efficient and scalable quantum low-density parity-check error correction codes, capable of performance approaching the theoretical hashing bound, has been developed by scientists at Institute of Science Tokyo, Japan. These novel error-correction codes can handle quantum codes with hundreds of thousands of qubits, potentially enabling large-scale fault-tolerant quantum computing, with applications in diverse fields, including quantum chemistry and optimization problems.
In recent years, quantum computers have begun to handle double-digit quantum bits, or qubits. However, many essential applications targeted by quantum computers, such as quantum chemistry, ...
2025-09-29
Rapidly aging populations and rising cases of lifestyle-related diseases (LRDs), like diabetes and hypertension, are driving significant financial strain on government budgets. While regular health checkups under a standardized government program can be a solution, it is not well understood how these initiatives benefit different socioeconomic sections of the society and their economic feasibility. Most studies have documented how health checkup programs affect salaried or employed workers, examining the program’s role in informing individuals about their health status and risks. However, ...
2025-09-29
DARIEN, IL – The Associated Professional Sleep Societies is accepting research abstracts and session proposal submissions for SLEEP 2026, the 40th annual meeting of the APSS, which will be held June 14 to 17 at the Baltimore Convention Center.
Research abstracts will be accepted for oral and poster presentations in two tracks: basic and translational sleep and circadian science and clinical sleep science and practice. Accepted abstracts will be published online in a supplement of the journal Sleep.
The APSS Program Committee is also accepting proposals for postgraduate courses and other sessions including bench-to-bedside sessions, clinical workshops, discussion ...
2025-09-29
A team led by UCL (University College London) and Imperial College London researchers has shown for the first time how life-saving antibiotics called polymyxins pierce the armour of harmful bacteria.
The findings, published in the journal Nature Microbiology, could lead to new treatments for bacterial infections – especially urgent since drug-resistant infections already kill more than a million people a year.
Polymyxins were discovered more than 80 years ago and are used as a last-resort treatment for infections caused ...
LAST 30 PRESS RELEASES:
[Press-News.org] American College of Cardiology issues scientific statement on inflammation and cardiovascular disease
